Atlas Trials

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Clinical trial NCT00323856 · COMPLETED

Trial details

NCT number
NCT00323856
Sponsor
Grifols Biologicals, LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Severe Hemophilia A
Start date
2003-04-08
Primary completion
2018-12-11
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.